| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo
|
Vermersch, Patrick
|
|
2017
|
|
3 |
|
artikel
|
| 2 |
Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis
|
Margoni, Monica
|
|
2019
|
|
3 |
|
artikel
|
| 3 |
Application of the Betty Neuman systems model in the nursing care of patients/clients with multiple sclerosis
|
Ahmadi, Zakieh
|
|
2017
|
|
3 |
|
artikel
|
| 4 |
Application of the McDonald criteria in Latin America
|
Patrucco, Liliana
|
|
2017
|
|
3 |
|
artikel
|
| 5 |
Cannabis-based product use in a multiple sclerosis cohort
|
Schabas, AJ
|
|
2019
|
|
3 |
|
artikel
|
| 6 |
Cerebrospinal fluid GAP-43 in early multiple sclerosis
|
Rot, U
|
|
2018
|
|
3 |
|
artikel
|
| 7 |
Changes in cortical motor outputs after a motor relapse of multiple sclerosis
|
Chieffo, Raffaella
|
|
2019
|
|
3 |
|
artikel
|
| 8 |
Cognitive and neuropsychiatric disorders among MS patients from Latin America
|
Vanotti, Sandra
|
|
2017
|
|
3 |
|
artikel
|
| 9 |
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up
|
Hersh, Carrie M
|
|
2017
|
|
3 |
|
artikel
|
| 10 |
Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience
|
Vollmer, Brandi
|
|
2017
|
|
3 |
|
artikel
|
| 11 |
Costs and quality of life by disability among people with multiple sclerosis: a register-based study in Sweden
|
Gyllensten, Hanna
|
|
2018
|
|
3 |
|
artikel
|
| 12 |
Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis
|
Srikajon, Jindapa
|
|
2018
|
|
3 |
|
artikel
|
| 13 |
Differential diagnosis of multiple sclerosis in Latin America
|
Fragoso, YD
|
|
2017
|
|
3 |
|
artikel
|
| 14 |
Disease-modifying therapies in multiple sclerosis in Latin America
|
Skromne-Eisenberg, Eli
|
|
2017
|
|
3 |
|
artikel
|
| 15 |
DNA methylation changes in CD4+ T cells isolated from multiple sclerosis patients on dimethyl fumarate
|
Maltby, Vicki E
|
|
2018
|
|
3 |
|
artikel
|
| 16 |
Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis
|
Gajamange, Sanuji
|
|
2019
|
|
3 |
|
artikel
|
| 17 |
Effects of vitamin D3 in clinically isolated syndrome and healthy control participants: A double-blind randomised controlled trial
|
O’Connell, Karen
|
|
2017
|
|
3 |
|
artikel
|
| 18 |
Efficacy of dimethyl fumarate in Japanese multiple sclerosis patients: interim analysis of randomized, double-blind APEX study and its open-label extension
|
Kondo, T
|
|
2019
|
|
3 |
|
artikel
|
| 19 |
Epidemiology of neuromyelitis optica in Latin America
|
Alvarenga, MP
|
|
2017
|
|
3 |
|
artikel
|
| 20 |
Healthcare expenditure of multiple sclerosis patients in 2013: A nationwide study based on French health administrative databases
|
Lefeuvre, Delphine
|
|
2017
|
|
3 |
|
artikel
|
| 21 |
High prevalence and indexes of anti-John Cunningham virus antibodies in a cohort of Chinese patients with multiple sclerosis
|
Lau, Alexander
|
|
2018
|
|
3 |
|
artikel
|
| 22 |
Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT)
|
Cleanthous, Sophie
|
|
2017
|
|
3 |
|
artikel
|
| 23 |
MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response
|
Pandit, Lekha
|
|
2018
|
|
3 |
|
artikel
|
| 24 |
MS in self-identified Hispanic/Latino individuals living in the US
|
Amezcua, Lilyana
|
|
2017
|
|
3 |
|
artikel
|
| 25 |
Objective and subjective measures of dalfampridine efficacy in clinical practice
|
Klineova, Sylvia
|
|
2018
|
|
3 |
|
artikel
|
| 26 |
Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders
|
Asseyer, Susanna
|
|
2018
|
|
3 |
|
artikel
|
| 27 |
Promotion of physical activity and exercise in multiple sclerosis: Importance of behavioral science and theory
|
Motl, Robert W
|
|
2018
|
|
3 |
|
artikel
|
| 28 |
Quantitative characterization of optic nerve atrophy in patients with multiple sclerosis
|
Harrigan, Robert L
|
|
2017
|
|
3 |
|
artikel
|
| 29 |
Reference videos reduce variability of motor dysfunction assessments in multiple sclerosis
|
D’Souza, Marcus
|
|
2018
|
|
3 |
|
artikel
|
| 30 |
Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study
|
Balk, Lisanne J
|
|
2019
|
|
3 |
|
artikel
|
| 31 |
Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis
|
Voortman, MM
|
|
2017
|
|
3 |
|
artikel
|
| 32 |
Serum retinol levels are associated with brain volume loss in patients with multiple sclerosis
|
Yokote, H
|
|
2017
|
|
3 |
|
artikel
|
| 33 |
Short-term prediction of secondary progression in a sliding window: A test of a predicting algorithm in a validation cohort
|
Skoog, B
|
|
2019
|
|
3 |
|
artikel
|
| 34 |
Testing patient-reported outcome measurement equivalence in multinational clinical trials: An exemplar using the 12-item Multiple Sclerosis Walking Scale
|
Dib, Hussein
|
|
2017
|
|
3 |
|
artikel
|
| 35 |
The challenges and opportunities of multiple sclerosis care in Latin America
|
Ontaneda, Daniel
|
|
2017
|
|
3 |
|
artikel
|
| 36 |
The effect of disease modifying therapies on CD62L expression in multiple sclerosis
|
Voortman, Margarete Maria
|
|
2018
|
|
3 |
|
artikel
|
| 37 |
The genetics of multiple sclerosis in Latin America
|
Rivas Alonso, Verónica
|
|
2017
|
|
3 |
|
artikel
|
| 38 |
Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting
|
Baldassari, Laura E
|
|
2019
|
|
3 |
|
artikel
|
| 39 |
Which symptoms contribute the most to patients’ perception of health in multiple sclerosis?
|
Green, Rivka
|
|
2017
|
|
3 |
|
artikel
|
Tijdschrift beschrijving